- $61.66m
- $103.27m
- $151.28m
- 64
- 74
- 34
- 59
Annual income statement for AstroNova, fiscal year end - January 31st, USD millions except per share, conversion factor applied.
2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | 2025 January 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 116 | 117 | 143 | 148 | 151 |
Cost of Revenue | |||||
Gross Profit | 41.4 | 43.7 | 48.2 | 53.7 | 52.7 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 114 | 109 | 137 | 139 | 160 |
Operating Profit | 2.43 | 8.72 | 5.44 | 8.8 | -8.64 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2.18 | 7.03 | 3.41 | 6.07 | -12.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.28 | 6.43 | 2.66 | 4.69 | -14.5 |
Net Income Before Extraordinary Items | |||||
Net Income | 1.28 | 6.43 | 2.66 | 4.69 | -14.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.28 | 6.43 | 2.66 | 4.69 | -14.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.179 | 0.406 | 0.361 | 0.964 | -0.665 |